Stockreport

TFF Pharmaceuticals Reports Continued Progress Across Programs in Corporate Update

TFF Pharmaceuticals, Inc.  (TFFP) 
PDF Continued clinical progress with lead compound Voriconazole Inhalation Powder, to treat invasive pulmonary aspergillosis (IPA)Tacrolimus Inhalation Powder for immunosupp [Read more]